Foods that might trigger Fibromyalgia

The following foods may worsen symptoms of fibromyalgia by increasing inflammation:

Sugar. Lowering or removing sugar can have a significant influence on wellness for two reasons. Initially, the clinical literature has actually shown that consuming foods high in sugar is linked to boosted fibromyalgia discomfort.

Second, limiting sugar assists control weight. Being obese puts added stress on the body, contributing to fatigue, and also kept fat might bring about inflammation in some cases. Sugar is a popular active ingredient in sweet as well as soft drinks, but is additionally in foods thought about to be healthy and balanced– such as yogurt. When inspecting nourishment tags, it is helpful to recognize that glucose, fructose, and sucrose are various other names for sugar.

Carbohydrates. Fine-tuned carbs such as cookies, several breads, breads, as well as white rice are absorbed quickly, creating blood sugar level levels to surge. The effect does not last, nonetheless, and also blood glucose quickly goes down, making the specific starving once more. These changes can make the fatigue and discomfort of fibromyalgia worse as well as contribute to overeating.

When eating carbohydrates, entire wheat resources ought to be selected. Entire wheat foods absorb a lot more slowly, preventing the highs and lows that accompany various other carbs.

One little research study focused on ladies identified with fibromyalgia that likewise had irritable digestive tract syndrome (IBS) and also a food intolerance. (Many individuals with fibromyalgia also have irritable bowel syndrome.).

When the ladies reduced on consuming a certain group of carbs, they reported a 50% reduction in short-tempered bowel signs and symptoms and a 22% decline in other signs, consisting of pain. The restricted carbohydrates were a type not well soaked up in the small intestine. Such carbohydrates include lactose (a component in milk and also other dairy products foods), fructose (in some vegetables and fruits, honey, and also various other sugar), as well as grains.

Processed foods. Sugar as well as harmful fats, which boost inflammation, are a big part of numerous processed foods. Flavors and preservatives typically utilized in processed foods likewise may set off food sensitivities.

Unhealthy fats. Veggie oils, such as corn oil, safflower oil, as well as peanut oil, have an inflammatory impact, especially when utilized to fry food. The clinical literature has actually linked deep-fried foods to aggravating of fibromyalgia signs. Harmful oils are an usual ingredient in numerous refined foods, such as cookies, doughnuts, and crackers. Pizza and cheese are additionally major resources of undesirable fats.

Alcohol. While some research study has located moderate alcohol use can reduce symptoms, some people with fibromyalgia report alcohol triggers signs to flare. Consuming alcohol while taking specific medicines prescribed for fibromyalgia– such as anti-convulsants, antidepressants, as well as acetaminophen (a component in several drugs) can create damaging interactions.

The above is not a comprehensive list of foods that may trigger symptoms. Other foods and ingredients that may trigger symptoms for some include, but are not limited to:

Red meat
Some fruits and vegetables
Dairy products

Mayo Clinic on Fibromyalgia: Strategies to Take Back Your Life
  • Abril M.D., Andy (Author)
  • English (Publication Language)
  • 272 Pages - 09/24/2019 (Publication Date) - Mayo Clinic Press (Publisher)

I get commissions for purchases made through links on this website. As an Amazon Associate I earn from qualifying purchases.

Research teams find widespread inflammation in the brains of fibromyalgia patients

A study by Massachusetts General Hospital (MGH) researchers – collaborating with a team at the Karolinska Institutet in Sweden – has documented for the first time widespread inflammation in the brains of patients with the poorly understood condition called fibromyalgia. Their report has been published online in the journal Brain, Behavior and Immunity.

“We don’t have good treatment options for fibromyalgia, so identifying a potential treatment target could lead to the development of innovative, more effective therapies,” says Marco Loggia, PhD, of the MGH-based Martinos Center for Biomedical Imaging, co-senior author of the report. “And finding objective neurochemical changes in the brains of patients with fibromyalgia should help reduce the persistent stigma that many patients face, often being told their symptoms are imaginary and there’s nothing really wrong with them.”

Characterized by symptoms including chronic widespread pain, sleep problems, fatigue, and problems with thinking and memory, fibromyalgia affects around 4 million adults in the U.S., according to the Centers for Disease Control and Prevention. Previous research from the Karolinska group led by Eva Kosek, MD, PhD, co-senior author of the current study, suggested a potential role for neuroinflammation in the condition – including elevated levels of inflammatory proteins in the cerebrospinal fluid – but no previous study has directly visualized neuroinflammation in fibromyalgia patients.

A 2015 study by Loggia’s team used combined MR/PET scanning to document neuroinflammation – specifically activation of glial cells – in the brains of patients with chronic back pain. Hypothesizing that similar glial activation might be found in fibromyalgia patients as well, his team used the same PET radiopharmaceutical, which binds to the translocator protein (TSPO) that is overexpressed by activated glial cells, in their study enrolling 20 fibromyalgia patients and 14 control volunteers.

At the same time, Kosek’s team at Karolinska had enrolled a group of 11 patients and an equal number of control participants for a similar study with the TSPO-binding PET tracer. Since that radiopharmaceutical binds to two types of glial cells – microglia and astrocytes – they also imaged 11 patients, 6 who had the TSPO imaging and 5 others, and another 11 controls with a PET tracer that is thought to bind preferentially to astrocytes and not to microglia. At both centers, participants with fibromyalgia completed questionnaires to assess their symptoms. When the MGH team became aware of the similar investigation the Karolinska group had underway, the teams decided to combine their data into a single study.

The results from both centers found that glial activation in several regions of the brains of fibromyalgia patients was significantly greater than it was in control participants. Compared to the MGH team’s chronic back pain study, TSPO elevations were more widespread throughout the brain, which Loggia indicates corresponds to the more complex symptom patterns of fibromyalgia. TSPO levels in a structure called the cingulate gyrus – an area associated with emotional processing where neuroinflammation has been reported in patients with chronic fatigue syndrome – corresponded with patients reported levels of fatigue. The Karolinska team’s studies with the astrocyte-binding tracer found little difference between patients and controls, suggesting that microglia were primarily responsible for the increased neuro-inflammation in fibromyalgia patients.

“The activation of glial cells we observed in our studies releases inflammatory mediators that are thought to sensitize pain pathways and contribute to symptoms such as fatigue,” says Loggia, an assistant professor of Radiology at Harvard Medical School. “The ability to join forces with our colleagues at Karolinska was fantastic, because combining our data and seeing similar results at both sites gives confidence to the reliability of our results.”

Mayo Clinic on Fibromyalgia: Strategies to Take Back Your Life
  • Abril M.D., Andy (Author)
  • English (Publication Language)
  • 272 Pages - 09/24/2019 (Publication Date) - Mayo Clinic Press (Publisher)

I get commissions for purchases made through links on this website. As an Amazon Associate I earn from qualifying purchases.

Concussion and Fibromyalgia: Is There A Link?

Fibromyalgia is an insidious disease. It’s challenging to diagnose with a host of complicated and differed symptoms, much of which can be attributed to other problems. These consist of, yet are not restricted to, increased sensitivity to pain, fatigue, memory loss and concerns with concentration, and also headaches. The specific root cause of fibromyalgia is unknown, yet study suggests it relates to chemical inequalities in the brain as well as, subsequently, exactly how the central nerves refines discomfort. Usually it’s thought to be triggered by a literally or emotionally traumatic event like the loss of a close friend or relative, giving birth, a severe medical procedure, or an injury. Such as, as an example, a terrible brain injury, also referred to as a concussion.

As we remain to learn more about fibromyalgia as well as its causes, so, as well, does the clinical area considerably discover more concerning concussion and traumatic brain injuries (TBI). Both are mostly misunderstood conditions, linked by injury to the brain as well as the nervous system. Thus, there are theories that head injury might result in fibromyalgia. But why? Just how does bumping your head after a fall link to a long-term incapacitating persistent pain condition? In the end, it’s all in your head!

When you strike your head, your brain tissue is wounded. This is, essentially, what a concussion is. Depending upon the level of seriousness of the injury, and exactly how treatment and recovery are approached, you can, in theory, be back up as well as running within a week or so. Nevertheless, most cases of TBI’s aren’t dealt with very carefully enough and result in long-lasting signs frequently characterized as post-concussion syndrome (PCS). Without appropriate therapy and also rest, concussions can end up being a months-long recovery process, and PCS can take anywhere up to a year to get over. This prolonged healing time implies that your brain is distressed for the duration, attempting to recoup however not able to heal from its preliminary contusion made considerably even worse by overuse.

It’s consequently medical experts are beginning to speculate a direct relationship between traumas, concussion, and fibromyalgia. Research studies on the cognitive function of clients with fibromyalgia lend really certain understandings into how the brain reacts to the problem. Evidence of declined handling speed, memory lapses, as well as fogginess are lastly being connected to the lasting effect of a concussion and also PCS, including enhanced recognizing to the consequences of fibromyalgia.

So what does this mean for people that have recuperated from a concussion? Are they imminently at risk of creating fibromyalgia? Should they rush to their doctors for an examination? No, not always. But what this does imply is, if you have actually experienced a concussion eventually in your life, and also you begin to discover some similar signs and symptoms resurfacing unexpectedly together with chronic, mysterious discomfort, it would concern discuss your previous TBI to your doctor or group of experts. Keeping a comprehensive medical history is essential, and can aid with future diagnoses. If you or someone you understand has actually suffered a concussion, take the needed time to rest and recoup to prevent long-term damage or PCS.

Mayo Clinic on Fibromyalgia: Strategies to Take Back Your Life
  • Abril M.D., Andy (Author)
  • English (Publication Language)
  • 272 Pages - 09/24/2019 (Publication Date) - Mayo Clinic Press (Publisher)

I get commissions for purchases made through links on this website. As an Amazon Associate I earn from qualifying purchases.

JOGO Health Launches COVID-19 Chronic Fatigue Syndrome Study

BRIDGEWATER, N.J., May 13, 2020 /PRNewswire/ — JOGOHEALTH Inc., a Bridgewater, New Jersey based privately held digital therapeutics company focused on the development and commercialization of treatments for neuromuscular (NM) and chronic pain conditions today announced that it will launch a study on COVID-19 related Myalgic Encephalomyelitis / Chronic Fatigue Syndrome (ME/CFS).

According to the patient advocacy group Solve ME/CFS Initiative, nearly 35% of COVID-19 patients are experiencing ME/CFS symptoms post infection. Since the onset of ME/CFS usually follows a viral infection, experts estimate up to 3,570,000 new ME/CFS cases following the COVID-19 pandemic. This would more than double the existing cases of ME/CFS in the United States in just 36 months, according to Solve ME/CFS Initiative.

“The science behind JOGO has shown to work for Fibromyalgia in many peer reviewed studies. Fibromyalgia and CFS/ME are both illnesses characterized by extreme amounts of fatigue. In fact, the conditions seem to be so intertwined that the medical community continues to debate whether fibromyalgia fatigue is simply a different expression of the same disorder that causes CFS. So, we approached some of the top experts the field of COVID and the researchers were convinced, JOGO is a potential candidate for ME/CFS,” said Siva Nadarajah, Co-Founder and President of JOGO Health Inc.

“We are excited by the opportunity to help patients, during post COVID-19 recovery phase. There are no treatments for ME/CFS yet – CDC has shown special interest in this condition as it impacts patients’ return to normal life. In a befitting honor to the memory of Florence Nightingale – who suffered from ME/CFS – her birthday, May12th, is marked as World ME/CFS Day,”  said Sanjai Murali, Founder and CEO of JOGO Health Inc.

According to CDC, prior to COVID-19, ME/CFS affected up to 2.5 million Americans. The Arthritis Foundation estimates that 50 to 70 percent of people with fibromyalgia also fit the criteria of ME/CFS

About JOGO Health.

JOGO Health is a digital therapeutic company that developed JOGO, a patent protected prescription digital therapeutics product to treat neuromuscular (NM) diseases, chronic pain, incontinence and chronic constipation. JOGO helps enhance rewiring of the CNS to improve voluntary control of muscles and neuromuscular reeducation.  JOGO is composed of wireless, wearable surface EMG sensors, and a patent protected Mobile App that provide treatment protocols and games that can be adapted for muscle relaxation, movement coordination, and neuro-muscular reeducation, all leveraging neuroplasticity. In March 2020, JOGO received FDA 510(K) Exemption for JOGO-Gx, its general purpose product for neuromuscular reeducation.

Mayo Clinic on Fibromyalgia: Strategies to Take Back Your Life
  • Abril M.D., Andy (Author)
  • English (Publication Language)
  • 272 Pages - 09/24/2019 (Publication Date) - Mayo Clinic Press (Publisher)

I get commissions for purchases made through links on this website. As an Amazon Associate I earn from qualifying purchases.

Ultralaser treatment for fibromyalgia yields 75 percent pain reduction when applied to the hands

A new device that combines low-intensity laser light and therapeutic ultrasound considerably reduces the pain experienced by patients with fibromyalgia.

A scientific study has shown that application to the palms instead of to tender points on different parts of the body has better analgesic and anti-inflammatory effects. As a result of pain reduction, patients also sleep better and are able to perform daily tasks with less discomfort. Their overall quality of life also improves.

In an article published in the Journal of Novel Physiotherapies, researchers at the Optics and Photonics Research Center (CEPOF), one of the Research, Innovation and Dissemination Centers (RIDCs) supported by the São Paulo Research Foundation – FAPESP, describe the concomitant application of low-intensity laser light and therapeutic ultrasound for three minutes to the palms of the hands of patients diagnosed with fibromyalgia. The treatment consisted of ten twice-weekly sessions.

“The study describes two innovations: the device and the treatment protocol. By emitting laser light and ultrasound simultaneously, we succeeded in normalizing the patient’s pain threshold. Application to the palms differs from the focus on tender points found practically everywhere today in fibromyalgia care,” said Antônio Eduardo de Aquino Junior, a researcher at the University of São Paulo’s São Carlos Physics Institute (IFSC-USP) in Brazil and a coauthor of the article.

The research was also funded by the National Council for Scientific and Technological Development (CNPq) and the Brazilian Innovation Agency (FINEP).

The principal investigator for the project was Vanderlei Salvador Bagnato, Full Professor and Director of IFSC-USP.

In the study, 48 women aged 40-65 and diagnosed with fibromyalgia were divided into six groups of eight at the Clinical Research Unit run by IFSC-USP in partnership with the Santa Casa de Misericórdia hospital in São Carlos, São Paulo State.

Three groups received applications of laser or ultrasound separately or combined in the region of the trapezius muscle. The other three groups received applications only to the palms.

The results showed that treatment involving application to the palms was more effective regardless of the technique, but the laser-ultrasound combination significantly improved the patients’ condition. Assessments were performed using the Fibromyalgia Impact Questionnaire (FIQ) and the Visual Analogue Scale for Pain (VASP).

A comparison of the groups showed a difference of 57.72% in functionality improvement and of 63.31% in pain reduction for the ultrasound-laser group in the case of application to the trapezius. Ultrasound-laser application to the palms produced a 73.37% difference in pain reduction compared with application to the trapezius.

Tender points

The idea of testing the effects of the new device in application to the palms of the hands arose from a review of the scientific literature.

“Previous studies showed that patients with fibromyalgia had larger numbers of neuroreceptors near blood vessels in the hands. Some patients even had red points in this region. We therefore changed focus to test the direct action of the technique on these sensory cells in the hands rather than just so-called pain trigger points, such as the trapezius, which is typically very painful in fibromyalgia patients,” said Juliana da Silva Amaral Bruno, a physical therapist and first author of the study.

The study showed that application to the hands affects all pain points in the patient’s body. The same FAPESP-funded center group had previously published an article in the Journal of Novel Physiotherapies describing a case study in applying the device to pain points. Although the results of this first study were satisfactory, global pain reduction proved impossible.

“Combined application of ultrasound and laser to pain points such as the trapezius was highly effective but did not succeed in reaching the other main innervations affected by the disorder,” Bruno said. “Application to the palms of the hands had a global result, restoring the patient’s quality of life and eliminating her pain.”

According to the study, the optimization of peripheral and brain blood flow via the activation of sensitive areas of the hands during the sessions normalized the patient’s pain threshold.

“It’s important to bear in mind that this isn’t a cure but a form of treatment that doesn’t require the use of drugs,” Aquino said.

Fibromyalgia is a chronic disease that involves widespread nonarticular high-intensity pain lasting longer than three months. It affects 3% to 10% of the adult population, with a higher prevalence in women. Although patients experience pain in practically the entire body, they do not present with injuries, inflammation or tissue degeneration. Two other mysteries are associated with fibromyalgia: its cause is unknown, and no cure has been found so far.

The standard treatment comprises physical exercise, anti-inflammatory and analgesic medication, and psychotherapy, as patients typically complain of extreme fatigue, difficulty concentrating, dizziness, depression and anxiety.

According to Aquino, the new device that combines ultrasound and laser therapy should come to market in early 2019. It is currently being tested for other pathologies by researchers at the FAPESP RIDC.

“We’re testing it for osteoarthritis, knees, hands and feet, and the results have been interesting. Other projects are being designed for other diseases,” Aquino said.

Mayo Clinic on Fibromyalgia: Strategies to Take Back Your Life
  • Abril M.D., Andy (Author)
  • English (Publication Language)
  • 272 Pages - 09/24/2019 (Publication Date) - Mayo Clinic Press (Publisher)

I get commissions for purchases made through links on this website. As an Amazon Associate I earn from qualifying purchases.

Does insulin resistance cause fibromyalgia?

GALVESTON, Texas – Researchers led by a team from The University of Texas Medical Branch at Galveston were able to dramatically reduce the pain of fibromyalgia patients with medication that targeted insulin resistance.

This discovery could dramatically alter the way that chronic pain can be identified and managed. Dr. Miguel Pappolla, UTMB professor of neurology, said that although the discovery is very preliminary, it may lead to a revolutionary shift on how fibromyalgia and related forms of chronic pain are treated. The new approach has the potential to save billions of dollars to the health care system and decrease many peoples’ dependence on opiates for pain management.

The UTMB team of researchers, along with collaborators from across the U.S., including the National Institutes of Health, were able for the first time, to separate patients with fibromyalgia from normal individuals using a common blood test for insulin resistance, or pre-diabetes. They then treated the fibromyalgia patients with a medication targeting insulin resistance, which dramatically reduced their pain levels. The study was recently published in PlosOne.

Fibromyalgia is one of the most common conditions causing chronic pain and disability. The global economic impact of fibromyalgia is enormous – in the U.S. alone and related health care costs are about $100 billion each year. Despite extensive research the cause of fibromyalgia is unknown, so there’s no specific diagnostics or therapies for this condition other than pain-reducing drugs.

“Earlier studies discovered that insulin resistance causes dysfunction within the brain’s small blood vessels. Since this issue is also present in fibromyalgia, we investigated whether insulin resistance is the missing link in this disorder,” Pappolla said. “We showed that most – if not all – patients with fibromyalgia can be identified by their A1c levels, which reflects average blood sugar levels over the past two to three months.”

Pre-diabetics with slightly elevated A1c values carry a higher risk of developing central (brain) pain, a hallmark of fibromyalgia and other chronic pain disorders.”

The researchers identified patients who were referred to a subspecialty pain medicine clinic to be treated for widespread muscular/connective tissue pain. All patients who met the criteria for fibromyalgia were separated into smaller groups by age. When compared with age-matched controls, the A1c levels of the fibromyalgia patients were significantly higher.

“Considering the extensive research on fibromyalgia, we were puzzled that prior studies had overlooked this simple connection,” said Pappolla. “The main reason for this oversight is that about half of fibromyalgia patients have A1c values currently considered within the normal range. However, this is the first study to analyze these levels normalized for the person’s age, as optimal A1c levels do vary throughout life. Adjustment for the patients’ age was critical in highlighting the differences between patients and control subjects.”

For the fibromyalgia patients, metformin, a drug developed to combat insulin resistance was added to their current medications. They showed dramatic reductions in their pain levels.

Mayo Clinic on Fibromyalgia: Strategies to Take Back Your Life
  • Abril M.D., Andy (Author)
  • English (Publication Language)
  • 272 Pages - 09/24/2019 (Publication Date) - Mayo Clinic Press (Publisher)

I get commissions for purchases made through links on this website. As an Amazon Associate I earn from qualifying purchases.